Comparison Overview
Gilead Sciences España y Portugal
Gilead Sciences España y Portugal
N/A
Last Update: 01/02/2026
Durante más de 35 años, en Gilead hemos conseguido avances que parecían imposibles, lo que nos ha permitido transformar la vida de miles de pacientes con enfermedades graves. Somos una compañía biofarmacéutica puntera, con productos en áreas como el VIH, las hepatitis v...
ICON plc
ICON plc, South County Business Park, Leopardstown, Dublin, IE, D18 X5R3
Last Update: 02/04/2026
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with ...
Compliance Ranges Comparison

Gilead Sciences España y Portugal






ICON plc






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Gilead Sciences España y Portugal in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for ICON plc in 2026.
Incident History - Gilead Sciences España y Portugal (X = Date, Y = Severity)
Gilead Sciences España y Portugal cyber incidents detection timeline including parent company and subsidiaries.
Incident History - ICON plc (X = Date, Y = Severity)
ICON plc cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Gilead Sciences España y Portugal
ICON plc
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.